Also trades as: KNE.V (TSXV) · $vol 0M
KNBIF OTC
Kane Biotech Inc.
1W: +3.2%
1M: -0.2%
3M: -5.3%
YTD: -30.6%
1Y: -43.7%
3Y: -75.4%
5Y: -89.8%
$0.02
-0.00 (-2.79%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.8M
52W Range0.01038-0.0338
Volume91,000
Avg Volume107,239
Beta0.31
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORobert Huizinga
Employees20
SectorHealthcare
IndustryBiotechnology
IPO Date2007-08-07
Websitekanebiotech.com
290-100 Innovation Drive
Winnipeg, MB R3T 6G2
CA
Winnipeg, MB R3T 6G2
CA
+1 204 477 7592
About Kane Biotech Inc.
Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB for treating wounds in both animals and humans. They also manufacture Alosera shampoos for dogs, cats, and horses, and Aledex coatings for medical devices. Additionally, Kane Biotech provides DermaKB products for scalp health, Coactiv+ for wound management, and other offerings such as goldstem, silkstem, and DermaKB Biofilm. Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada.
Recent Insider Trades
No insider trades found